FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation. [electronic resource]
Producer: 20190705Description: 261-276 p. digitalISSN:- 1879-0631
- Adaptor Proteins, Signal Transducing
- Animals
- Bone and Bones -- drug effects
- Cell Differentiation
- Cells, Cultured
- Dexamethasone -- toxicity
- Fibroblast Growth Factor 2 -- pharmacology
- Glucocorticoids -- toxicity
- Glycoproteins -- antagonists & inhibitors
- Intercellular Signaling Peptides and Proteins
- Mice
- Muscle, Skeletal -- drug effects
- Musculoskeletal Diseases -- chemically induced
- Myostatin -- antagonists & inhibitors
- Osteoblasts -- cytology
- Osteogenesis -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.